No correlations were found between MBL and HOMA-β or HOMA-IR and no significant differences in MBL serum levels were found in T2D patients treated with insulin compared to those treated with other anti-diabetic medication or with lifestyle intervention alone. This evidence concerns the gene MBL2 and type 2 diabetes mellitus.